Jazz Pharmaceuticals (JAZZ) 189.42 $JAZZ
Big Pharma Comes Under Attack From a New Hedge Fund Strategy
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 26, 10:04AM CDT
Source: Teva Pharmaceutical, Facebook. Forget retail short-sellers and angry message board posters, Big Pharma has a much bigger concern on the horizon: hedge funds. I know what you're probably thinking, "Haven't various hedge funds already been...
ACT: 295.41 (-2.95), SHPG: 255.11 (-0.26), PFE: 35.27 (-0.09), JAZZ: 189.42 (+0.33), TEVA: 64.41 (+1.16)
Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015
PR Newswire Europe - Thu Apr 23, 3:06PM CDT
Jazz Pharmaceuticals plc today announced that it will report its 2015 first quarter financial results on Thursday, May 7, 2015, after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EDT/9:30 p.m. IST to discuss first quarter 2015 financial results and provide a business and financial update.
JAZZ: 189.42 (+0.33)
EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors
PR Newswire - Tue Apr 21, 3:00AM CDT
EUSA Pharma (EUSA), a recently-established profitable specialty pharmaceutical company with global reach, today announced the appointment of Lee Morley as Chief Executive Officer, and Dr Göran Ando as a Non-Executive Director. Bryan Morton, who established EUSA Pharma as founder and first CEO, will become Executive Chairman.
JAZZ: 189.42 (+0.33)
This New Hedge Fund Strategy Just Might Be Crazy Enough To Work
Matthew Frankel, The Motley Fool - Motley Fool - Sun Apr 19, 1:07PM CDT
Hedge funds use a lot of strategies to make money, but one manager is doing something we've never seen before in order to make a profit -- challenging a company's patents and shorting its stock simultaneously. How exactly does it work, and will it...
SHPG: 255.11 (-0.26), JAZZ: 189.42 (+0.33), ACOR: 33.12 (-0.38)
Will This Hedge Fund Manager Bring Down Your Biotech Stocks?
Selena Maranjian, The Motley Fool - Motley Fool - Sun Apr 19, 12:01PM CDT
Hedge-fund manager Kyle Bass. Image: Insider Monkey Many hedge-fund managers are "activist" ones. They load up on stock in particular companies until they have so many shares that they can put pressure on management to take actions they...
SHPG: 255.11 (-0.26), JAZZ: 189.42 (+0.33), ACOR: 33.12 (-0.38)
Insider Trading Alert - REIS, JAZZ And COTY Traded By Insiders
at The Street - Fri Apr 17, 10:15AM CDT
Stocks with insider trader activity include REIS, JAZZ and COTY
REIS: 25.75 (+0.26), COTY: 24.78 (-0.22), JAZZ: 189.42 (+0.33)
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 1.56% Gain
Comtex SmarTrend(R) - Thu Apr 16, 4:22PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $186.08 to a high of $190.48. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $187.43 on volume of 662,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JAZZ: 189.42 (+0.33)
4 Big Biopharma Deals We Might See In 2015
Sy Mukherjee - Seeking Alpha - Thu Apr 16, 1:29PM CDT
In 2000, UK-based Glaxo Wellcome joined forces with SmithKline Beecham in a $74 billion merger that birthed the global pharma giant GlaxoSmithKline (NYSE: GSK ). It was, far and away, the biggest biopharma deal of the year. What a difference 14...
BMRN: 120.28 (-2.67), PCYC: 256.59 (-0.51), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20), GSK: 46.59 (+0.28), HSP: 87.61 (-0.05), CELG: 118.71 (+2.62), SGEN: 37.14 (-0.36), GILD: 103.69 (-1.52), SHPG: 255.11 (-0.26), AZN: 71.79 (-1.34), JAZZ: 189.42 (+0.33), MRK: 57.60 (+0.09), ABBV: 66.07 (+1.82)
Autohome, Other Foreign Stock Leaders Seen Posting Big Q1
at Investor's Business Daily - Mon Apr 13, 4:17PM CDT
With earnings season now upon us, analysts see profit for the S&P 500 getting dinged by the energy sector. But a number of top-rated foreign stocks are slated to deliver big profit growth. Analysts polled by Thomson Reuters see Autohome's (ATHM)...
ENDP: 93.27 (-0.81), VRX: 210.42 (+1.03), JAZZ: 189.42 (+0.33), FLTX: 46.62 (-1.73), ATHM: 53.31 (+0.92)
Jazz Pharmaceuticals Rises 6.80% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Apr 08, 4:01PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $169.77 to a high of $180.25. Yesterday, the shares gained 6.8%, which took the trading range above the 3-day high of $174.30 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JAZZ: 189.42 (+0.33)
Top China Stocks Dominate; Which Are Near Buy Points?
at Investor's Business Daily - Tue Apr 07, 5:05PM CDT
U.S. stocks gave up intraday gains to close with minor losses Tuesday, despite an assist from a handful of international players. Foreign stocks made up nearly a third of Investors.com's Stocks On The Move column, though some faded by the close....
NOAH: 33.79 (+0.63), RYAAY: 67.00 (+0.51), NTES: 122.19 (+3.26), JAZZ: 189.42 (+0.33), CMCM: 24.11 (+0.13), INFY: 31.81 (-3.15), ATHM: 53.31 (+0.92)
Jazz Pharmaceuticals Could Be A Buy, Depending On Investment Strategy
William Meyers - at Seeking Alpha - Mon Apr 06, 9:41AM CDT
JAZZ: 189.42 (+0.33)
Look for Shares of Jazz Pharmaceuticals to Potentially Rebound after Yesterday's 1.27% Sell Off
Comtex SmarTrend(R) - Thu Apr 02, 4:29PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $167.34 to a high of $174.30. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $168.56 on volume of 861,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JAZZ: 189.42 (+0.33)
Suitors allegedly eyeing Italian pharma firm's rare diseases unit
Seeking Alpha - at Seeking Alpha - Mon Mar 30, 12:03PM CDT
SHPG: 255.11 (-0.26), JAZZ: 189.42 (+0.33)
Insider Trading Alert - KCG, RSE And JAZZ Traded By Insiders
at The Street - Mon Mar 30, 10:15AM CDT
Stocks with insider trader activity include KCG, RSE and JAZZ
KCG: 13.09 (+0.09), JAZZ: 189.42 (+0.33), RSE: 18.24 (+0.09)
InsiderInsights.com Daily Round Up 3/27/15: COCP, GPRO, SJW, AGCO
InsiderInsights - at Seeking Alpha - Sun Mar 29, 12:55PM CDT
GPRO: 44.73 (-1.35), HCOM: 26.37 (-0.03), DPLO: 36.71 (+0.46), AGCO: 48.31 (-0.56), ENV: 54.31 (-0.22), LPI: 14.72 (-0.32), GOOG: 565.06 (+18.06), NOW: 76.09 (-0.79), ARMK: 31.66 (+0.20), JAZZ: 189.42 (+0.33), GLF: 13.58 (-0.05), SJW: 30.41 (+0.43), JGW: 10.58 (-0.03), ALCO: 47.11 (-0.65), FI: 18.80 (-0.36), CRM: 67.83 (-0.64)
Insider Weekends - March 27, 2015
Asif Suria - at Seeking Alpha - Sun Mar 29, 1:46AM CDT
Welcome to edition 249 of Insider Weekends. Insider buying declined sharply last week with insiders buying $27.48 million of stock compared to $148.24 million in the week prior. Selling also decreased with insiders selling $1.37 billion of stock last...
PN: 14.13 (+0.44), FEYE: 44.03 (+0.10), MMI: 37.42 (-0.40), OPK: 14.83 (+0.17), JAZZ: 189.42 (+0.33), PHII: 31.74 (-0.26), SLG: 128.82 (+1.47), SJW: 30.41 (+0.43), ROST: 104.38 (-0.13), FI: 18.80 (-0.36)
Marine Biotechnology - Global Strategic Business Report 2015-2020: A Science to Address Global Challenges
M2 - Thu Mar 26, 6:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hcgcbk/marine) has announced the addition of the "Marine Biotechnology - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. The report profiles 84 companies including many key and niche players such as: - Aker BioMarine AS (Norway) - Aqua Bio Technology ASA (Norway) - BASF SE (Germany) - CP Kelco (US) - Cyanotech Corp. (US) - Nutrex Hawaii (US) - FMC Health and Nutrition (US) - NovaMatrix (Norway) - GlycoMar Ltd. (UK) - Jazz Pharmaceuticals plc (Ireland) - Lonza Group Ltd. (Switzerland) - Marinova Pty Ltd (Australia) - New England Biolabs Inc (US) - oceanBASIS GmbH (Germany) - PharmaMar S.A (Spain) - PML Applications Ltd. (UK) - Prolume Ltd (US) - BioLume?, Inc. (US) - Royal DSM N.V (Netherlands) - Sea Run Holdings, Inc. (US) - SEPPIC (France) - Biotech Marine (France) - Tequesta BioVentures (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. A REVIEW OF END-USE MARKETS/ APPLICATIONS 3. R&D ACTIVITY IN MARINE BIOTECHNOLOGY - A REVIEW 4. MARINE BIOTECHNOLOGY - AN OVERVIEW 5. KEY RESEARCH FINDINGS ON MARINE ORGANISMS 6. PRODUCT INTRODUCTIONS/INNOVATIONS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 84 (including Divisions/Subsidiaries - 89) - The United States (25) - Canada (1) - Japan (2) - Europe (44) - - France (4) - - Germany (4) - - The United Kingdom (4) - - Spain (2) - - Rest of Europe (30) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/hcgcbk/marine
CYAN: 9.11 (-0.13), JAZZ: 189.42 (+0.33)
Watch for Jazz Pharmaceuticals to Potentially Rebound After Falling 3.62% Yesterday
Comtex SmarTrend(R) - Mon Mar 23, 4:41PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $181.64 to a high of $188.21. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $182.60 on volume of 873,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JAZZ: 189.42 (+0.33)
Big Pharma Comes Under Attack From a New Hedge Fund Strategy
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 26, 10:04AM CDT
Source: Teva Pharmaceutical, Facebook. Forget retail short-sellers and angry message board posters, Big Pharma has a much bigger concern on the horizon: hedge funds. I know what you're probably thinking, "Haven't various hedge funds already been...
ACT: 295.41 (-2.95), SHPG: 255.11 (-0.26), PFE: 35.27 (-0.09), JAZZ: 189.42 (+0.33), TEVA: 64.41 (+1.16)
Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015
PR Newswire Europe - Thu Apr 23, 3:06PM CDT
Jazz Pharmaceuticals plc today announced that it will report its 2015 first quarter financial results on Thursday, May 7, 2015, after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EDT/9:30 p.m. IST to discuss first quarter 2015 financial results and provide a business and financial update.
JAZZ: 189.42 (+0.33)
EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors
PR Newswire - Tue Apr 21, 3:00AM CDT
EUSA Pharma (EUSA), a recently-established profitable specialty pharmaceutical company with global reach, today announced the appointment of Lee Morley as Chief Executive Officer, and Dr Göran Ando as a Non-Executive Director. Bryan Morton, who established EUSA Pharma as founder and first CEO, will become Executive Chairman.
JAZZ: 189.42 (+0.33)
This New Hedge Fund Strategy Just Might Be Crazy Enough To Work
Matthew Frankel, The Motley Fool - Motley Fool - Sun Apr 19, 1:07PM CDT
Hedge funds use a lot of strategies to make money, but one manager is doing something we've never seen before in order to make a profit -- challenging a company's patents and shorting its stock simultaneously. How exactly does it work, and will it...
SHPG: 255.11 (-0.26), JAZZ: 189.42 (+0.33), ACOR: 33.12 (-0.38)
Will This Hedge Fund Manager Bring Down Your Biotech Stocks?
Selena Maranjian, The Motley Fool - Motley Fool - Sun Apr 19, 12:01PM CDT
Hedge-fund manager Kyle Bass. Image: Insider Monkey Many hedge-fund managers are "activist" ones. They load up on stock in particular companies until they have so many shares that they can put pressure on management to take actions they...
SHPG: 255.11 (-0.26), JAZZ: 189.42 (+0.33), ACOR: 33.12 (-0.38)
Insider Trading Alert - REIS, JAZZ And COTY Traded By Insiders
at The Street - Fri Apr 17, 10:15AM CDT
Stocks with insider trader activity include REIS, JAZZ and COTY
REIS: 25.75 (+0.26), COTY: 24.78 (-0.22), JAZZ: 189.42 (+0.33)
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 1.56% Gain
Comtex SmarTrend(R) - Thu Apr 16, 4:22PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $186.08 to a high of $190.48. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $187.43 on volume of 662,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JAZZ: 189.42 (+0.33)
4 Big Biopharma Deals We Might See In 2015
Sy Mukherjee - Seeking Alpha - Thu Apr 16, 1:29PM CDT
In 2000, UK-based Glaxo Wellcome joined forces with SmithKline Beecham in a $74 billion merger that birthed the global pharma giant GlaxoSmithKline (NYSE: GSK ). It was, far and away, the biggest biopharma deal of the year. What a difference 14...
BMRN: 120.28 (-2.67), PCYC: 256.59 (-0.51), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20), GSK: 46.59 (+0.28), HSP: 87.61 (-0.05), CELG: 118.71 (+2.62), SGEN: 37.14 (-0.36), GILD: 103.69 (-1.52), SHPG: 255.11 (-0.26), AZN: 71.79 (-1.34), JAZZ: 189.42 (+0.33), MRK: 57.60 (+0.09), ABBV: 66.07 (+1.82)
Autohome, Other Foreign Stock Leaders Seen Posting Big Q1
at Investor's Business Daily - Mon Apr 13, 4:17PM CDT
With earnings season now upon us, analysts see profit for the S&P 500 getting dinged by the energy sector. But a number of top-rated foreign stocks are slated to deliver big profit growth. Analysts polled by Thomson Reuters see Autohome's (ATHM)...
ENDP: 93.27 (-0.81), VRX: 210.42 (+1.03), JAZZ: 189.42 (+0.33), FLTX: 46.62 (-1.73), ATHM: 53.31 (+0.92)
Jazz Pharmaceuticals Rises 6.80% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Apr 08, 4:01PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $169.77 to a high of $180.25. Yesterday, the shares gained 6.8%, which took the trading range above the 3-day high of $174.30 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JAZZ: 189.42 (+0.33)
Top China Stocks Dominate; Which Are Near Buy Points?
at Investor's Business Daily - Tue Apr 07, 5:05PM CDT
U.S. stocks gave up intraday gains to close with minor losses Tuesday, despite an assist from a handful of international players. Foreign stocks made up nearly a third of Investors.com's Stocks On The Move column, though some faded by the close....
NOAH: 33.79 (+0.63), RYAAY: 67.00 (+0.51), NTES: 122.19 (+3.26), JAZZ: 189.42 (+0.33), CMCM: 24.11 (+0.13), INFY: 31.81 (-3.15), ATHM: 53.31 (+0.92)
Jazz Pharmaceuticals Could Be A Buy, Depending On Investment Strategy
William Meyers - at Seeking Alpha - Mon Apr 06, 9:41AM CDT
JAZZ: 189.42 (+0.33)
Look for Shares of Jazz Pharmaceuticals to Potentially Rebound after Yesterday's 1.27% Sell Off
Comtex SmarTrend(R) - Thu Apr 02, 4:29PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $167.34 to a high of $174.30. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $168.56 on volume of 861,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JAZZ: 189.42 (+0.33)
Suitors allegedly eyeing Italian pharma firm's rare diseases unit
Seeking Alpha - at Seeking Alpha - Mon Mar 30, 12:03PM CDT
SHPG: 255.11 (-0.26), JAZZ: 189.42 (+0.33)
Insider Trading Alert - KCG, RSE And JAZZ Traded By Insiders
at The Street - Mon Mar 30, 10:15AM CDT
Stocks with insider trader activity include KCG, RSE and JAZZ
KCG: 13.09 (+0.09), JAZZ: 189.42 (+0.33), RSE: 18.24 (+0.09)
InsiderInsights.com Daily Round Up 3/27/15: COCP, GPRO, SJW, AGCO
InsiderInsights - at Seeking Alpha - Sun Mar 29, 12:55PM CDT
GPRO: 44.73 (-1.35), HCOM: 26.37 (-0.03), DPLO: 36.71 (+0.46), AGCO: 48.31 (-0.56), ENV: 54.31 (-0.22), LPI: 14.72 (-0.32), GOOG: 565.06 (+18.06), NOW: 76.09 (-0.79), ARMK: 31.66 (+0.20), JAZZ: 189.42 (+0.33), GLF: 13.58 (-0.05), SJW: 30.41 (+0.43), JGW: 10.58 (-0.03), ALCO: 47.11 (-0.65), FI: 18.80 (-0.36), CRM: 67.83 (-0.64)
Insider Weekends - March 27, 2015
Asif Suria - at Seeking Alpha - Sun Mar 29, 1:46AM CDT
Welcome to edition 249 of Insider Weekends. Insider buying declined sharply last week with insiders buying $27.48 million of stock compared to $148.24 million in the week prior. Selling also decreased with insiders selling $1.37 billion of stock last...
PN: 14.13 (+0.44), FEYE: 44.03 (+0.10), MMI: 37.42 (-0.40), OPK: 14.83 (+0.17), JAZZ: 189.42 (+0.33), PHII: 31.74 (-0.26), SLG: 128.82 (+1.47), SJW: 30.41 (+0.43), ROST: 104.38 (-0.13), FI: 18.80 (-0.36)
Marine Biotechnology - Global Strategic Business Report 2015-2020: A Science to Address Global Challenges
M2 - Thu Mar 26, 6:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hcgcbk/marine) has announced the addition of the "Marine Biotechnology - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. The report profiles 84 companies including many key and niche players such as: - Aker BioMarine AS (Norway) - Aqua Bio Technology ASA (Norway) - BASF SE (Germany) - CP Kelco (US) - Cyanotech Corp. (US) - Nutrex Hawaii (US) - FMC Health and Nutrition (US) - NovaMatrix (Norway) - GlycoMar Ltd. (UK) - Jazz Pharmaceuticals plc (Ireland) - Lonza Group Ltd. (Switzerland) - Marinova Pty Ltd (Australia) - New England Biolabs Inc (US) - oceanBASIS GmbH (Germany) - PharmaMar S.A (Spain) - PML Applications Ltd. (UK) - Prolume Ltd (US) - BioLume?, Inc. (US) - Royal DSM N.V (Netherlands) - Sea Run Holdings, Inc. (US) - SEPPIC (France) - Biotech Marine (France) - Tequesta BioVentures (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. A REVIEW OF END-USE MARKETS/ APPLICATIONS 3. R&D ACTIVITY IN MARINE BIOTECHNOLOGY - A REVIEW 4. MARINE BIOTECHNOLOGY - AN OVERVIEW 5. KEY RESEARCH FINDINGS ON MARINE ORGANISMS 6. PRODUCT INTRODUCTIONS/INNOVATIONS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 84 (including Divisions/Subsidiaries - 89) - The United States (25) - Canada (1) - Japan (2) - Europe (44) - - France (4) - - Germany (4) - - The United Kingdom (4) - - Spain (2) - - Rest of Europe (30) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/hcgcbk/marine
CYAN: 9.11 (-0.13), JAZZ: 189.42 (+0.33)
Watch for Jazz Pharmaceuticals to Potentially Rebound After Falling 3.62% Yesterday
Comtex SmarTrend(R) - Mon Mar 23, 4:41PM CDT
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $181.64 to a high of $188.21. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $182.60 on volume of 873,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JAZZ: 189.42 (+0.33)
